Welcome to MedsFacts the next generation reference for medication safety. With more than 70% of all Americans currently taking at least one prescription drug – and at least 50% of all Americans taking two or more medications – it’s more critical than ever that we are informed, engaged and aware of potential side effects and adverse reactions.

MedsFacts is the premiere destination for the latest prescription drug and healthcare news. MedsFacts analyzes more than 18 million FDA adverse drug reports for 20,000 different pharmaceutical products, enabling patients and providers to better understand the potential side effects of different medications, along with potentially harmful interactions. Our easy-to-use online tools help you quickly assess the benefits and potential dangers associated with different medications. These easy-to-use diagnostic tools empower you to take charge of your health!

In conjunction with our redesigned website launch, the MedsFacts team is excited to announce our newest feature: the ability to consult with expert physicians and scientific researchers about different prescription medications. Patients can ask questions about their medications, providers can post responses to patient concerns, and patients can also schedule a personal consultation with a medication expert – all from within the MedsFacts website.

Using our community forum, you can share your own experience with different medications. Did you find that the side effects for a specific drug did not seem to apply to you? Or maybe you experienced other difficulties while taking a specific medication. Share your experiences and interact with other patients who are also taking similar medications for similar health concerns.

As a registered MedsFacts user, you can privately and securely save your medication list to the cloud. Once you’ve saved your medication list, you can receive regular updates from other patients posting questions or concerns about the same medications on your watch list. You control your communication preferences so you only receive the updates that are most relevant to your health concerns.

Wondering whether it is safe to take two medications together? Confused about your medical provider’s prescriptions? Curious if others are experiencing the same side effects as you? Sign up for MedsFacts today. Joining MedsFacts is completely free and will give you access to all our easy-to-use tools, including expert physician and researcher consultations and our community forums. You’ll be able to view user comments and concerns, and interact with patients who take similar medications.

Stay informed and take control of your health: click here to join the growing MedsFacts community.

 

About this MedsFacts analysis covering adverse side effect reports of SAPHRIS patients who developed ANGER.

MedsFacts provides MD-approved analysis to help both patients, researchers, and physicians accurately assess the risk profile for more than 20,000 different pharmaceutical products. The below report offers compiled information from Food & Drug Administration and MedsFacts user submissions. Between January 2004 and October 2012, 39 individuals taking SAPHRIS reported ANGER to the FDA. A total of 3790 SAPHRIS drug adverse event reaction reports were made with the FDA during this time period. Often the FDA only receives reports of the most critical and severe cases; these numbers may therefore underrepresent the complication rate of the medication.

FDA Research Report

Introduction This page is designed to help you determine the relationship, if any, between SAPHRIS and ANGER. In doing so, we compare SAPHRIS with other drugs that cause ANGER, to help you evaluate whether or not SAPHRIS causes ANGER. Likewise, this page shows the most highly-reported side effects of SAPHRIS, so you can see if ANGER ranks among SAPHRIS's most well-known side effects.
Summary Statistics
Reports of SAPHRIS causing ANGER: 39
Reports of any side effect of SAPHRIS : 3790
Percentage of SAPHRIS patients where ANGER is a reported side effect: 1.0290%

FDA reports of any drug causing ANGER : 12263
Average percentage for all medicated patients where ANGER is reported as a complication: 0.0769%

Physician opinion on SAPHRIS as adverse event culprit:

Overall opinion for all reports of this drug:
Most frequent diagnoses/indications for prescribing SAPHRIS:
BIPOLAR DISORDER ( 1106 patients )
PRODUCT USED FOR UNKNOWN INDICATION ( 950 patients )
DRUG USE FOR UNKNOWN INDICATION ( 706 patients )
SCHIZOPHRENIA ( 357 patients )
BIPOLAR I DISORDER ( 150 patients )
SCHIZOAFFECTIVE DISORDER ( 91 patients )
PSYCHOTIC DISORDER ( 80 patients )
DEPRESSION ( 56 patients )
MANIA ( 36 patients )
AFFECTIVE DISORDER ( 25 patients )
MAJOR DEPRESSION ( 18 patients )
ANXIETY ( 17 patients )
SCHIZOAFFECTIVE DISORDER BIPOLAR TYPE ( 17 patients )
BIPOLAR II DISORDER ( 12 patients )
MENTAL DISORDER ( 11 patients )
PARANOIA ( 10 patients )
HALLUCINATION ( 8 patients )
INSOMNIA ( 8 patients )
DELUSION ( 7 patients )
SCHIZOPHRENIFORM DISORDER ( 7 patients )
AGITATION ( 7 patients )
POST-TRAUMATIC STRESS DISORDER ( 7 patients )
SCHIZOPHRENIA, PARANOID TYPE ( 6 patients )
OBSESSIVE-COMPULSIVE DISORDER ( 6 patients )
SUICIDAL IDEATION ( 4 patients )
ASPERGER'S DISORDER ( 4 patients )
DELUSIONAL DISORDER, UNSPECIFIED TYPE ( 4 patients )
ANXIETY DISORDER ( 4 patients )
OFF LABEL USE ( 3 patients )
ANGER ( 3 patients )
GENERALISED ANXIETY DISORDER ( 3 patients )
HALLUCINATION, AUDITORY ( 3 patients )
AGGRESSION ( 2 patients )
SLEEP DISORDER ( 2 patients )
DEMENTIA ALZHEIMER'S TYPE ( 2 patients )
AUTISM ( 2 patients )
NERVOUS SYSTEM DISORDER ( 2 patients )
PANIC DISORDER ( 2 patients )
DEPRESSED MOOD ( 2 patients )
DEPRESSION SUICIDAL ( 2 patients )
ATTENTION DEFICIT/HYPERACTIVITY DISORDER ( 2 patients )
MOOD SWINGS ( 2 patients )
SCHIZOTYPAL PERSONALITY DISORDER ( 1 patients )
BRAIN OPERATION ( 1 patients )
HALLUCINATION, VISUAL ( 1 patients )
AGORAPHOBIA ( 1 patients )
SOCIAL PHOBIA ( 1 patients )
INTERMITTENT EXPLOSIVE DISORDER ( 1 patients )
TOURETTE'S DISORDER ( 1 patients )
DISABILITY ( 1 patients )
SCHIZOAFFECTIVE DISORDER DEPRESSIVE TYPE ( 1 patients )
MOOD DISORDER DUE TO A GENERAL MEDICAL CONDITION ( 1 patients )
ENERGY INCREASED ( 1 patients )
BORDERLINE PERSONALITY DISORDER ( 1 patients )
SELF INJURIOUS BEHAVIOUR ( 1 patients )
CRYING ( 1 patients )
HYPOMANIA ( 1 patients )
SLEEP DISORDER THERAPY ( 1 patients )
AKATHISIA ( 1 patients )
INTENTIONAL DRUG MISUSE ( 1 patients )
SUBSTANCE ABUSE ( 1 patients )
PSYCHOTIC BEHAVIOUR ( 1 patients )
ANTISOCIAL PERSONALITY DISORDER ( 1 patients )
IRRITABILITY ( 1 patients )
TACHYPHRENIA ( 1 patients )
PULMONARY EMBOLISM ( 1 patients )
DRUG THERAPY ( 1 patients )
MOOD ALTERED ( 1 patients )
EATING DISORDER ( 1 patients )
FATIGUE ( 1 patients )
SCHIZOPHRENIA, UNDIFFERENTIATED TYPE ( 1 patients )
OBSESSIVE THOUGHTS ( 1 patients )
( 0 patients )
Drugs with high FDA adverse event association with ANGER:

CHANTIX (2705 patients)
SEROQUEL (1332 patients)
PAXIL (804 patients)
CYMBALTA (670 patients)
ACCUTANE (646 patients)
XANAX (564 patients)
ZOLOFT (559 patients)
EFFEXOR XR (534 patients)
SINGULAIR (530 patients)
NEURONTIN (518 patients)
STRATTERA (481 patients)
KLONOPIN (435 patients)
LEXAPRO (413 patients)
PROZAC (398 patients)
EFFEXOR (371 patients)
WELLBUTRIN (346 patients)
ASPIRIN (320 patients)
LYRICA (318 patients)
AMBIEN (309 patients)
PAROXETINE HCL (302 patients)
PRISTIQ (301 patients)
LAMICTAL (299 patients)
CLONAZEPAM (295 patients)
RISPERDAL (292 patients)
OXYCONTIN (275 patients)
TRAZODONE HCL (272 patients)
ZYPREXA (270 patients)
NEXIUM (244 patients)
SYNTHROID (242 patients)
LIPITOR (242 patients)
LISINOPRIL (240 patients)
SIMVASTATIN (240 patients)
DIAZEPAM (232 patients)
TYSABRI (232 patients)
KEPPRA (221 patients)
DEPAKOTE (220 patients)
PEG-INTRON (217 patients)
ALBUTEROL (217 patients)
TOPAMAX (210 patients)
CELEXA (209 patients)
ATIVAN (204 patients)
VIOXX (203 patients)
ABILIFY (202 patients)
SEROQUEL XR (197 patients)
RIBAVIRIN (193 patients)
PEGASYS (193 patients)
GABAPENTIN (192 patients)
PRILOSEC (187 patients)
CELEBREX (184 patients)
ATENOLOL (179 patients)
LORAZEPAM (174 patients)
TOPROL-XL (173 patients)
IBUPROFEN (172 patients)
VALIUM (170 patients)
GEODON (165 patients)
MIRTAZAPINE (163 patients)
WELLBUTRIN XL (159 patients)
PERCOCET (159 patients)
LEVOTHYROXINE SODIUM (156 patients)
PAXIL CR (153 patients)
VYVANSE (152 patients)
ALPRAZOLAM (152 patients)
METFORMIN HCL (151 patients)
CITALOPRAM HYDROBROMIDE (150 patients)
PREDNISONE (149 patients)
OMEPRAZOLE (149 patients)
VICODIN (148 patients)
HYDROCHLOROTHIAZIDE (147 patients)
AVONEX (145 patients)
REBIF (141 patients)
ZOCOR (140 patients)
FOSAMAX (140 patients)
ADVAIR DISKUS 100/50 (136 patients)
ALL OTHER THERAPEUTIC PRODUCTS (132 patients)
LITHIUM CARBONATE (130 patients)
CONCERTA (125 patients)
CHAMPIX (124 patients)
COPEGUS (123 patients)
TRILEPTAL (122 patients)
SOMA (118 patients)
PLAVIX (116 patients)
RESTORIL (116 patients)
MOTRIN (116 patients)
HALDOL (115 patients)
PREVACID (115 patients)
PAROXETINE HYDROCHLORIDE (115 patients)
NAMENDA (113 patients)
OXYCODONE HCL (112 patients)
VITAMIN D (112 patients)
LORTAB (111 patients)
RISPERIDONE (111 patients)
ZYRTEC (109 patients)
CRESTOR (108 patients)
PROTONIX (107 patients)
CLONIDINE (107 patients)
BETASERON (106 patients)
RITALIN (106 patients)
SEROXAT (105 patients)
FOLIC ACID (104 patients)
SANDOSTATIN LAR (102 patients)
DURAGESIC-100 (102 patients)
NICOTINE (101 patients)
FLUOXETINE (99 patients)
LAMOTRIGINE (97 patients)
LASIX (97 patients)
COUMADIN (94 patients)
HYDROCODONE (94 patients)
AMITRIPTYLINE HCL (93 patients)
MIRENA (92 patients)
FLEXERIL (90 patients)
NITROGLYCERIN (89 patients)
ACETAMINOPHEN (88 patients)
LEVAQUIN (88 patients)
POTASSIUM CHLORIDE (87 patients)
VISTARIL (87 patients)
BUSPAR (86 patients)
TRAZODONE (86 patients)
TRAMADOL HCL (85 patients)
FORTEO (84 patients)
FUROSEMIDE (84 patients)
COGENTIN (83 patients)
NAPROXEN (82 patients)
TEMAZEPAM (81 patients)
CLOZARIL (81 patients)
TEGRETOL (79 patients)
REMERON (79 patients)
PREMARIN (79 patients)
WELLBUTRIN SR (79 patients)
DARVOCET (77 patients)
ZANTAC (77 patients)
MULTI-VITAMINS (77 patients)
PROMETHAZINE (77 patients)
TRICOR (76 patients)
VARENICLINE TARTRATE (75 patients)
LANTUS (75 patients)
YAZ (74 patients)
REBETOL (73 patients)
PROVIGIL (73 patients)
TYLENOL (CAPLET) (72 patients)
ALCOHOL (72 patients)
YASMIN (71 patients)
LITHIUM (71 patients)
LUNESTA (71 patients)
FISH OIL (70 patients)
HYDROXYZINE (70 patients)
NORVASC (68 patients)
VITAMINS (68 patients)
DILANTIN (67 patients)
PROPRANOLOL (67 patients)
BUPROPION HYDROCHLORIDE (67 patients)
ELAVIL (67 patients)
CLARITIN (67 patients)
OXYCODONE (66 patients)
RANITIDINE (65 patients)
ZANAFLEX (65 patients)
SERTRALINE HYDROCHLORIDE (65 patients)
ENBREL (65 patients)
RIBASPHERE (64 patients)
ZITHROMAX (64 patients)
METOPROLOL TARTRATE (64 patients)
ACTIQ (64 patients)
DIGOXIN (64 patients)
HUMALOG (64 patients)
ACETYLSALICYLIC ACID (63 patients)
VYTORIN (63 patients)
VENLAFAXINE HCL (63 patients)
INVEGA SUSTENNA (62 patients)
METFORMIN (62 patients)
BENADRYL (62 patients)
VITAMIN B-12 (61 patients)
TYLENOL (61 patients)
BUPROPION HCL (61 patients)
LEVOXYL (61 patients)
INSULIN (61 patients)
CALCIUM (61 patients)
ZOMETA (60 patients)
AMLODIPINE (59 patients)
ADDERALL 10 (59 patients)
SUBOXONE (59 patients)
MIRAPEX (59 patients)
ARICEPT (58 patients)
HUMIRA (57 patients)
RISPERDAL CONSTA (57 patients)
SAVELLA (57 patients)
AZITHROMYCIN (57 patients)
AMNESTEEM (56 patients)
IMITREX (56 patients)
CARISOPRODOL (56 patients)
LANSOPRAZOLE (56 patients)
DAYTRANA (55 patients)
NO CONCURRENT MEDICATION (55 patients)
VITAMIN TAB (55 patients)
LARIAM (54 patients)
ZETIA (54 patients)
FLONASE (54 patients)
SKELAXIN (54 patients)
VALPROIC ACID (54 patients)
BACLOFEN (54 patients)
SYMBICORT (53 patients)
METOPROLOL (52 patients)
DEPAKOTE ER (50 patients)
COFFEE (50 patients)
HYDROCODONE BITARTRATE (50 patients)
ALLEGRA (50 patients)
DEPAKENE (49 patients)
ASCORBIC ACID (49 patients)
NUVARING (49 patients)
ADVIL (48 patients)
MORPHINE SULFATE (48 patients)
BECLAMIDE (47 patients)
Most common side effects for patients taking SAPHRIS:
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION (414 patients)
DYSGEUSIA (282 patients)
UNDERDOSE (241 patients)
HYPOAESTHESIA ORAL (218 patients)
INCORRECT ROUTE OF DRUG ADMINISTRATION (190 patients)
WEIGHT INCREASED (184 patients)
DIZZINESS (164 patients)
NAUSEA (162 patients)
SOMNOLENCE (140 patients)
SEDATION (118 patients)
VOMITING (116 patients)
SWOLLEN TONGUE (115 patients)
AKATHISIA (114 patients)
INSOMNIA (101 patients)
AGITATION (99 patients)
OEDEMA PERIPHERAL (97 patients)
FEELING ABNORMAL (87 patients)
TREMOR (81 patients)
DYSPNOEA (81 patients)
ANXIETY (80 patients)
DYSTONIA (73 patients)
RASH (72 patients)
MANIA (71 patients)
FATIGUE (70 patients)
HYPOAESTHESIA (69 patients)
SUICIDAL IDEATION (66 patients)
EXTRAPYRAMIDAL DISORDER (66 patients)
HEADACHE (59 patients)
CONVULSION (59 patients)
DEPRESSION (59 patients)
DYSPHAGIA (56 patients)
RESTLESS LEGS SYNDROME (56 patients)
GLOSSODYNIA (50 patients)
OFF LABEL USE (49 patients)
DYSKINESIA (47 patients)
DEATH (46 patients)
TARDIVE DYSKINESIA (45 patients)
WRONG TECHNIQUE IN DRUG USAGE PROCESS (43 patients)
DRUG HYPERSENSITIVITY (43 patients)
DRUG INEFFECTIVE (43 patients)
PSYCHOTIC DISORDER (41 patients)
BLOOD GLUCOSE INCREASED (40 patients)
RESTLESSNESS (40 patients)
ANGER (39 patients)
GAIT DISTURBANCE (39 patients)
CONDITION AGGRAVATED (39 patients)
PARANOIA (39 patients)
SYNCOPE (38 patients)
ORAL DISCOMFORT (37 patients)
CONFUSIONAL STATE (36 patients)
AGGRESSION (35 patients)
FALL (34 patients)
OVERDOSE (33 patients)
SWELLING FACE (33 patients)
MUSCLE SPASMS (32 patients)
HALLUCINATION (32 patients)
COMPLETED SUICIDE (32 patients)
DYSARTHRIA (31 patients)
MUSCULOSKELETAL STIFFNESS (31 patients)
VISION BLURRED (31 patients)
SPEECH DISORDER (30 patients)
HYPERHIDROSIS (30 patients)
ANGIOEDEMA (29 patients)
PHARYNGEAL OEDEMA (29 patients)
LOSS OF CONSCIOUSNESS (28 patients)
STOMATITIS (27 patients)
PAIN IN EXTREMITY (27 patients)
DROOLING (27 patients)
DRUG DOSE OMISSION (27 patients)
HYPERSENSITIVITY (27 patients)
CHEST PAIN (27 patients)
PARAESTHESIA (26 patients)
OEDEMA (25 patients)
DISORIENTATION (25 patients)
INCREASED APPETITE (25 patients)
ARTHRALGIA (25 patients)
JOINT SWELLING (25 patients)
TOOTH DISCOLOURATION (24 patients)
HYPOTENSION (24 patients)
ANAPHYLACTIC REACTION (24 patients)
OROPHARYNGEAL BLISTERING (24 patients)
NIGHTMARE (24 patients)
MUSCLE TWITCHING (22 patients)
TONGUE BLISTERING (22 patients)
MOUTH ULCERATION (22 patients)
HYPERTENSION (22 patients)
PAIN (22 patients)
HEART RATE INCREASED (22 patients)
PANIC ATTACK (22 patients)
DIARRHOEA (22 patients)
THROAT TIGHTNESS (21 patients)
TONGUE DISORDER (21 patients)
SALIVARY HYPERSECRETION (21 patients)
MIGRAINE (20 patients)
ASTHENIA (20 patients)
BALANCE DISORDER (20 patients)
BLOOD PRESSURE INCREASED (20 patients)
INCORRECT DOSE ADMINISTERED (20 patients)
NERVOUSNESS (20 patients)
PSYCHOMOTOR HYPERACTIVITY (20 patients)
HALLUCINATION, AUDITORY (20 patients)
IRRITABILITY (19 patients)
THERAPEUTIC PRODUCT INEFFECTIVE (19 patients)
PALPITATIONS (19 patients)
URTICARIA (19 patients)
MYALGIA (18 patients)
WEIGHT DECREASED (18 patients)
CONSTIPATION (18 patients)
HYPERSOMNIA (17 patients)
TACHYCARDIA (16 patients)
MYOCARDIAL INFARCTION (16 patients)
TONGUE ULCERATION (16 patients)
GALACTORRHOEA (16 patients)
PRURITUS (16 patients)
RASH GENERALISED (16 patients)
SUICIDE ATTEMPT (16 patients)
CONTUSION (16 patients)
ALOPECIA (15 patients)
AMNESIA (15 patients)
MUSCLE TIGHTNESS (15 patients)
PYREXIA (15 patients)
ABNORMAL BEHAVIOUR (14 patients)
AGEUSIA (14 patients)
ANAPHYLACTIC SHOCK (14 patients)
MEMORY IMPAIRMENT (14 patients)
SOMNAMBULISM (14 patients)
PHARYNGEAL HYPOAESTHESIA (14 patients)
HEAD INJURY (14 patients)
CHOKING (14 patients)
LIP SWELLING (14 patients)
COUGH (14 patients)
MALAISE (14 patients)
ERYTHEMA (14 patients)
SCHIZOPHRENIA (14 patients)
STEVENS-JOHNSON SYNDROME (13 patients)
ENURESIS (13 patients)
HUNGER (13 patients)
INJURY (13 patients)
CEREBROVASCULAR ACCIDENT (13 patients)
CHEST DISCOMFORT (13 patients)
SWELLING (13 patients)
DECREASED APPETITE (13 patients)
WHITE BLOOD CELL COUNT DECREASED (13 patients)
ABDOMINAL PAIN (12 patients)
LACERATION (12 patients)
FEELING DRUNK (12 patients)
BIPOLAR DISORDER (12 patients)
BLOOD PROLACTIN INCREASED (12 patients)
PRODUCT TASTE ABNORMAL (12 patients)
TREATMENT NONCOMPLIANCE (12 patients)
UNEVALUABLE EVENT (12 patients)
DELUSION (12 patients)
PALLOR (12 patients)
ORTHOSTATIC HYPOTENSION (11 patients)
LETHARGY (11 patients)
HYPOMANIA (11 patients)
DRY MOUTH (11 patients)
BACK PAIN (11 patients)
DYSSTASIA (11 patients)
THINKING ABNORMAL (11 patients)
MOVEMENT DISORDER (11 patients)
DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (11 patients)
PULMONARY EMBOLISM (11 patients)
DRUG INTOLERANCE (11 patients)
TACHYPHRENIA (11 patients)
MENTAL DISORDER (10 patients)
PNEUMONIA (10 patients)
ADVERSE EVENT (10 patients)
DRUG INTERACTION (10 patients)
ATAXIA (10 patients)
BLOOD CHOLESTEROL INCREASED (10 patients)
BLOOD PRESSURE DECREASED (10 patients)
UNRESPONSIVE TO STIMULI (10 patients)
EYE MOVEMENT DISORDER (10 patients)
FEELING JITTERY (10 patients)
ABASIA (9 patients)
ABDOMINAL DISCOMFORT (9 patients)
ABDOMINAL DISTENSION (9 patients)
FLUID RETENTION (9 patients)
GUN SHOT WOUND (9 patients)
APATHY (9 patients)
MUSCLE RIGIDITY (9 patients)
ARRHYTHMIA (9 patients)
INTENTIONAL SELF-INJURY (9 patients)
HOSPITALISATION (9 patients)
DISTURBANCE IN ATTENTION (9 patients)
EMOTIONAL DISORDER (9 patients)
ABDOMINAL PAIN UPPER (8 patients)
LIVER FUNCTION TEST ABNORMAL (8 patients)
MUSCULAR WEAKNESS (8 patients)
AMENORRHOEA (8 patients)
LOSS OF LIBIDO (8 patients)
FEELING HOT (8 patients)
TONGUE DISCOLOURATION (8 patients)
BIPOLAR I DISORDER (8 patients)
EUPHORIC MOOD (8 patients)
MOOD ALTERED (8 patients)
FLUSHING (8 patients)
PARKINSONISM (8 patients)
SLEEP DISORDER (8 patients)
NO THERAPEUTIC RESPONSE (8 patients)
HEPATIC ENZYME INCREASED (8 patients)
LOCAL SWELLING (8 patients)
MEDICATION ERROR (8 patients)
PAIN IN JAW (8 patients)
PARAESTHESIA ORAL (8 patients)
SELF-MEDICATION (7 patients)
HOT FLUSH (7 patients)
THROMBOCYTOPENIA (7 patients)
BLOOD POTASSIUM DECREASED (7 patients)

In addition to reviewing our up-to-date FDA research, users may interact with the MedsFacts community - currently one million members and growing! MedsFacts online research and discussions are read by patients, scientists, physicians, and other interested health care parties. Post follow up Questions to learn from our diverse readership. Likewise, patients who have experienced unwanted effects are encouraged to share their Concerns to help educate and inform our members.


Recent MedsFacts Activity for SAPHRIS


Issue Description / Topic Timestamp

My Patient Resources

Get your questions answered! Over one million patients, researchers, and health care providers have visited MedsFacts. If you have a question about ANGER and SAPHRIS, post it here. You may receive a response from a fellow patient - or a leading expert in the field.
Your Question:

Share your experience: Over one million patients, researchers, and health care providers have visited MedsFacts. If you have a noteworthy experience as a patient taking SAPHRIS, post it here. Your story could help a fellow patient - or provide insight to a leading expert in the field.
Your Experience or Concern:

Telemedicine Expert Consults MedsFacts newest feature allows patients to consult - via realtime videoconferencing - experts in SAPHRIS. This premium feature connects patients to experts, regardless of geography. MedsFacts experts charge reasonable rates that may be reimbursable by your insurance as a second-opinion.
We are currently accepting registration for SAPHRIS experts. If you are a healthcare provider experienced in prescribing SAPHRIS, please register here.
© 2014 MedsFacts, Inc
Privacy Policy
Terms of Use